ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 145 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,827,142 | -18.5% | 345,485 | -8.5% | 0.00% | 0.0% |
| Q2 2023 | $10,833,182 | +43.3% | 377,726 | +19.8% | 0.00% | 0.0% |
| Q1 2023 | $7,560,186 | +44.5% | 315,402 | +2.2% | 0.00% | +100.0% |
| Q4 2022 | $5,232,295 | +7.7% | 308,508 | -5.9% | 0.00% | 0.0% |
| Q3 2022 | $4,858,000 | -23.0% | 327,795 | -18.2% | 0.00% | 0.0% |
| Q2 2022 | $6,311,000 | -17.0% | 400,937 | +42.2% | 0.00% | -50.0% |
| Q1 2022 | $7,602,000 | -24.8% | 281,990 | +3.2% | 0.00% | 0.0% |
| Q4 2021 | $10,115,000 | +50.0% | 273,324 | +93.7% | 0.00% | +100.0% |
| Q3 2021 | $6,743,000 | +239.0% | 141,128 | +140.1% | 0.00% | – |
| Q2 2021 | $1,989,000 | -73.9% | 58,781 | -68.1% | 0.00% | -100.0% |
| Q1 2021 | $7,615,000 | -64.1% | 184,377 | -62.3% | 0.00% | -60.0% |
| Q4 2020 | $21,231,000 | +14.8% | 489,401 | +13.6% | 0.01% | 0.0% |
| Q3 2020 | $18,486,000 | +396.7% | 430,903 | +441.2% | 0.01% | +400.0% |
| Q2 2020 | $3,722,000 | +330.8% | 79,617 | +25.2% | 0.00% | – |
| Q1 2020 | $864,000 | +591.2% | 63,594 | +454.6% | 0.00% | – |
| Q4 2019 | $125,000 | – | 11,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SEVEN EIGHT CAPITAL, LP | 46,819 | $2,031,000 | 0.47% |
| Orbimed Advisors | 1,206,886 | $49,844,000 | 0.47% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 25,000 | $1,033,000 | 0.40% |
| ARK Investment Management | 3,331,889 | $137,607,000 | 0.27% |
| FEDERATED HERMES, INC. | 3,203,000 | $132,284,000 | 0.26% |
| MGO ONE SEVEN LLC | 26,990 | $1,114,000 | 0.19% |
| Koss-Olinger Consulting, LLC | 20,000 | $826,000 | 0.14% |
| Jump Financial, LLC | 35,400 | $1,462,000 | 0.14% |
| Graham Capital Management, L.P. | 74,262 | $3,067,000 | 0.14% |
| New England Research & Management, Inc. | 6,005 | $248,000 | 0.14% |